Robert DeMichiei insider trades: Ardent Health (ARDT) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | ARDT | ↑ Buy | 11,260 | $8.73 | $98K | Direct | Jun 8, 2026 (3d) |
| Mar 23, 2023 | AP | ↑ Buy | 18,182 | $2.29 | $42K | Direct | Mar 24, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ARDT insiders
Open-market trades in the last 12 months
About Robert DeMichiei's insider trades
Robert DeMichiei is a director at Ardent Health (ARDT). Since Mar 23, 2023, Robert has reported 2 open-market purchases worth $140K and no sales on SEC Form 4. In the last 12 months: 1 buy ($98K).
Their filings also include grants and awards (10 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARDT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.